Phase II of doxorubicin/taxol in metastatic breast cancer. Argentine Multicenter Taxol Group.
Pazos C, Mickiewicz E, Di Notto MR, Cóppola F, Ventriglia M, Jovtis S, Balbiani L, Lewi D, Róndinón M, Témperley G, Trigo M, Bertoncín AM, Pascual M, Uranga G, Cazap E, Breier S, Grasso S, Estévez R, Triguboff E, Alvarez A, Suárez A.
Pazos C, et al. Among authors: grasso s.
Breast Cancer Res Treat. 1999 May;55(1):91-6. doi: 10.1023/a:1006194909859.
Breast Cancer Res Treat. 1999.
PMID: 10472783
Clinical Trial.